Federal regulators have accused Morgan Stanley of “astonishing” failures that led to the mishandling of sensitive data on some 15 million customers, writes Matt Egan.
Elon Musk’s brain-computer interface company Neuralink says it has received Food and Drug Administration (FDA) approval to launch its first in-human clinical study, writes Sean Hollister and Jay Peters.